The antipsychotic medication, risperidone, causes global immunosuppression in healthy mice
Open Access
- 26 June 2019
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 14 (6) , e0218937
Abstract
Atypical antipsychotic medications such as risperidone are widely prescribed for diverse psychiatric indications including schizophrenia, bipolar disorder and depression. These medications have complex pharmacology and are associated with significant endocrine and metabolic side effects. This class of medications also carries FDA black box warnings due to increased risk of death in elderly patients. Clinical reports indicate that patients treated with these medications are more susceptible to infections; however, the underlying mechanisms/pharmacology are unclear. We have previously reported that risperidone and it’s active metabolite distributes to the bone marrow in clinically relevant concentrations in preclinical species, leading us to hypothesize that the hematopoietic system may be impacted by these medications. To test this hypothesis, using proteomic and cytokine array technology, we evaluated the expression of genes involved in inflammatory and immune function following short term (5 days) and longer term (4 weeks) treatment in healthy animals. We report that low-dose risperidone treatment results in global immunosuppression in mice, observed following 5 days of dosing and exacerbated with longer term drug treatment (4 weeks). These data are consistent with increased susceptibility to infection in patients administered these medications and have profound implications for the increasing off-label prescribing to vulnerable patient populations including children and the elderly.Keywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (DK095143)
This publication has 59 references indexed in Scilit:
- Risperidone-induced leukopenia: a case report and brief review of literatureGeneral Hospital Psychiatry, 2013
- Targeted Data Extraction of the MS/MS Spectra Generated by Data-independent Acquisition: A New Concept for Consistent and Accurate Proteome AnalysisMolecular & Cellular Proteomics, 2012
- Measles virus, immune control, and persistenceFEMS Microbiology Reviews, 2012
- Trabecular bone loss after administration of the second-generation antipsychotic risperidone is independent of weight gainBone, 2012
- Receptor mechanisms of antipsychotic drug action in bipolar disorder – focus on asenapineTherapeutic Advances in Psychopharmacology, 2011
- Neuronal stimulation with 5-hydroxytryptamine 4 receptor induces anti-inflammatory actions via α7nACh receptors on muscularis macrophages associated with postoperative ileusGut, 2010
- Weight Gain and Metabolic Abnormalities During Extended Risperidone Treatment in Children and AdolescentsJournal of Child and Adolescent Psychopharmacology, 2009
- Dopamine D2 Receptor Polymorphisms in Inflammatory Bowel Disease and the Refractory Response to TreatmentDigestive Diseases and Sciences, 2006
- Serum IL‐1β, sIL‐2R, IL‐6, IL‐8 and TNF‐α in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatmentMediators of Inflammation, 2001
- CLOZAPINE AND AGRANULOCYTOSISThe Lancet, 1977